Kevin Hrusovsky

Dr. Kevin Hrusovsky serves as Board Member at BioIVT. He also serves as Executive Chairman and Chief Executive Officer at Quanterix. Dr. Hrusovsky was appointed President and CEO of Caliper Life Sciences immediately following the acquisition of Zymark Corporation by Caliper in July 2003. Prior to the acquisition, Dr. Hrusovsky served as President and CEO for Zymark starting in late 1996. Dr. Hrusovsky successfully transformed Zymark from a custom robotics company into a formidable Life Sciences "Tools" company through acquisitions, R&D investment and recruitment of top industry talent. Before joining Zymark, Dr. Hrusovsky was president of the Pharmaceutical Division at FMC and ran the Teflon and other specialty businesses at Dupont. His entire career has been associated with managing transformative innovation into sustainable profitable enterprises. He is on the Global Research Council for Children's Hospital, Boston and is a member of the Advisory Committee for the Center for Biomedical Engineering at Brown University. He received an Honorary Doctorate degree from Framingham State University for contributions to life sciences. Dr. Hrusovsky holds a BSME from Ohio State and M.B.A. from Ohio University. Dr. Hrusovsky served as a Board Member at SynapDx. Previously, Hrusovsky served as president of life sciences and technology at PerkinElmer. He also holds an MBA (Master of Business Administration) degree from Ohio State University and a Degree from Harvard University.